Drugs / 68Ga-NODAGA-Exendin-4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05622123 | Feb 2023 → Feb 2024 | type 1 diabetes mellitus | Radboud University Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-NODAGA-Exendin-4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05622123 ↗ |
| Modality | Diagnostic / imaging agent | “PET/CT imaging after injection with 68Ga-NODAGA-exendin-4” NCT05622123 ↗ |